SSTR2 and neoplasm: Surprisingly, the widely used 99mTc ligand HYNIC along with the co-ligand edda resulted in almost complete loss of sst2 binding affinity, whereas 99mTc-SS-04 demonstrated impressive tumour uptake and high tumour-to-normal organ ratios.